FM19G11-Loaded Gold Nanoparticles Enhance the Proliferation and Self-Renewal of Ependymal Stem Progenitor Cells Derived from ALS Mice
Stefania Marcuzzo,
Davide Isaia,
Silvia Bonanno,
Claudia Malacarne,
Paola Cavalcante,
Antonella Zacheo,
Valentino Laquintana,
Nunzio Denora,
Barbara Sanavio,
Elisa Salvati,
Patrizia Andreozzi,
Francesco Stellacci,
Silke Krol,
Maravillas Mellado-López,
Renato Mantegazza,
Victoria Moreno-Manzano,
Pia Bernasconi
Affiliations
Stefania Marcuzzo
Neurology IV—Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico “Carlo Besta”, 20133 Milan, Italy
Davide Isaia
Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Department of Development and Stem Cells, CNRS UMR7104, INSERM U964, Université de Strasbourg, 67404 Illkirch CU Strasbourg, France
Silvia Bonanno
Neurology IV—Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico “Carlo Besta”, 20133 Milan, Italy
Claudia Malacarne
Neurology IV—Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico “Carlo Besta”, 20133 Milan, Italy
Paola Cavalcante
Neurology IV—Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico “Carlo Besta”, 20133 Milan, Italy
Antonella Zacheo
Laboratory for Translational Nanotechnology, IRCCS Istituto Tumori “Giovanni Paolo II”, 70124 Bari, Italy
Valentino Laquintana
Department of Pharmacy—Pharmaceutical Sciences, University of Bari “Aldo Moro”, 70124 Bari, Italy
Nunzio Denora
Department of Pharmacy—Pharmaceutical Sciences, University of Bari “Aldo Moro”, 70124 Bari, Italy
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease affecting motor neurons. In ALS mice, neurodegeneration is associated with the proliferative restorative attempts of ependymal stem progenitor cells (epSPCs) that normally lie in a quiescent in the spinal cord. Thus, modulation of the proliferation of epSPCs may represent a potential strategy to counteract neurodegeneration. Recent studies demonstrated that FM19G11, a hypoxia-inducible factor modulator, induces epSPC self-renewal and proliferation. The aim of the study was to investigate whether FM19G11-loaded gold nanoparticles (NPs) can affect self-renewal and proliferation processes in epSPCs isolated from G93A-SOD1 mice at disease onset. We discovered elevated levels of SOX2, OCT4, AKT1, and AKT3, key genes associated with pluripotency, self-renewal, and proliferation, in G93A-SOD1 epSPCs at the transcriptional and protein levels after treatment with FM19G11-loaded NPs. We also observed an increase in the levels of the mitochondrial uncoupling protein (UCP) gene in treated cells. FM19G11-loaded NPs treatment also affected the expression of the cell cycle-related microRNA (miR)-19a, along with its target gene PTEN, in G93A-SOD1 epSPCs. Overall our findings establish the significant impact of FM19G11-loaded NPs on the cellular pathways involved in self-renewal and proliferation in G93A-SOD1 epSPCs, thus providing an impetus to the design of novel tailored approaches to delay ALS disease progression.